Axa’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-7,600
| Closed | -$432K | – | 1309 |
|
|
2021
Q2 | $432K | Sell |
7,600
-30,319
| -80% | -$1.72M | ﹤0.01% | 1123 |
|
|
2021
Q1 | $2.84M | Sell |
37,919
-89,276
| -70% | -$6.68M | 0.01% | 797 |
|
|
2020
Q4 | $11M | Sell |
127,195
-2,182
| -2% | -$189K | 0.03% | 492 |
|
|
2020
Q3 | $7.91M | Sell |
129,377
-93,895
| -42% | -$5.74M | 0.03% | 524 |
|
|
2020
Q2 | $9.28M | Buy |
223,272
+178,821
| +402% | +$7.44M | 0.04% | 457 |
|
|
2020
Q1 | $1.28M | Sell |
44,451
-2,826
| -6% | -$81.2K | 0.01% | 816 |
|
|
2019
Q4 | $3.41M | Buy |
47,277
+1,080
| +2% | +$78K | 0.01% | 714 |
|
|
2019
Q3 | $6.48M | Sell |
46,197
-82
| -0.2% | -$11.5K | 0.03% | 573 |
|
|
2019
Q2 | $8.47M | Buy |
46,279
+1,009
| +2% | +$185K | 0.03% | 515 |
|
|
2019
Q1 | $7.2M | Hold |
45,270
| – | – | 0.03% | 541 |
|
|
2018
Q4 | $4.34M | Sell |
45,270
-24,300
| -35% | -$2.33M | 0.02% | 644 |
|
|
2018
Q3 | $9.83M | Sell |
69,570
-100
| -0.1% | -$14.1K | 0.04% | 485 |
|
|
2018
Q2 | $10.9M | Buy |
69,670
+6,676
| +11% | +$1.04M | 0.04% | 425 |
|
|
2018
Q1 | $10.1M | Buy |
62,994
+17,874
| +40% | +$2.88M | 0.04% | 440 |
|
|
2017
Q4 | $7.43M | Sell |
45,120
-1,344
| -3% | -$221K | 0.03% | 559 |
|
|
2017
Q3 | $2.9M | Buy |
46,464
+676
| +1% | +$42.1K | 0.01% | 752 |
|
|
2017
Q2 | $3.65M | Sell |
45,788
-1,721
| -4% | -$137K | 0.02% | 671 |
|
|
2017
Q1 | $3.38M | Sell |
47,509
-1,493
| -3% | -$106K | 0.02% | 673 |
|
|
2016
Q4 | $2.5M | Buy |
49,002
+927
| +2% | +$47.3K | 0.01% | 718 |
|
|
2016
Q3 | $2.21M | Buy |
48,075
+44
| +0.1% | +$2.03K | 0.01% | 736 |
|
|
2016
Q2 | $1.45M | Buy |
+48,031
| New | +$1.45M | 0.01% | 810 |
|